Halozyme Therapeutics Inc (HALO)

Days of inventory on hand (DOH)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Inventory turnover		1.37	1.56	1.32	1.21	1.51	1.41	1.32	1.47	1.39	1.15	0.92	1.66	1.51	1.54	1.25	0.96	0.71	0.59	1.05	1.13
DOH	days	265.61	233.77	276.13	302.62	242.12	258.29	276.67	247.52	262.34	317.38	395.70	220.34	241.69	237.31	292.46	381.64	511.28	623.39	348.56	324.09

December 31, 2024 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 1.37
= 265.61

The Days of Inventory on Hand (DOH) for Halozyme Therapeutics Inc has shown some fluctuations over the past few years. The company's DOH was relatively high at the end of 2020, reaching 623.39 days in September before decreasing to 237.31 days by the end of September 2021. This sharp decline in DOH indicates that the company was managing its inventory more efficiently during this period.

From September 2021 to June 2022, DOH increased to 395.70 days, suggesting a buildup in inventory possibly due to changes in production or demand patterns. However, the company managed to bring down its DOH to 220.34 days by the end of the first quarter of 2022, indicating better inventory management practices.

Over the following quarters, the DOH continued to fluctuate within a range, showcasing some level of volatility in the company's inventory management. By the end of December 2024, the DOH stood at 265.61 days. Overall, while Halozyme Therapeutics Inc has experienced fluctuations in its DOH, the company appears to be actively working towards optimizing its inventory levels to enhance efficiency and financial performance.